BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 10221340)

  • 1. Molecular cytogenetic analysis of the bladder carcinoma cell line BK-10 by spectral karyotyping.
    Padilla-Nash HM; Nash WG; Padilla GM; Roberson KM; Robertson CN; Macville M; Schröck E; Ried T
    Genes Chromosomes Cancer; 1999 May; 25(1):53-9. PubMed ID: 10221340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of chromosomal abnormalities in uroepithelial carcinomas by G-banding, spectral karyotyping and FISH analysis.
    Fadl-Elmula I; Kytölä S; Pan Y; Lui WO; Derienzo G; Forsberg L; Mandahl N; Gorunova L; Bergerheim US; Heim S; Larsson C
    Int J Cancer; 2001 Jun; 92(6):824-31. PubMed ID: 11351302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spectral karyotyping in patients with acute myeloid leukemia and a complex karyotype shows hidden aberrations, including recurrent overrepresentation of 21q, 11q, and 22q.
    Mrózek K; Heinonen K; Theil KS; Bloomfield CD
    Genes Chromosomes Cancer; 2002 Jun; 34(2):137-53. PubMed ID: 11979548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly comprehensive karyotype analysis by a combination of spectral karyotyping (SKY), microdissection, and reverse painting (SKY-MD).
    Weimer J; Koehler MR; Wiedemann U; Attermeyer P; Jacobsen A; Karow D; Kiechl M; Jonat W; Arnold N
    Chromosome Res; 2001; 9(5):395-402. PubMed ID: 11448041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hidden chromosome abnormalities in haematological malignancies detected by multicolour spectral karyotyping.
    Veldman T; Vignon C; Schröck E; Rowley JD; Ried T
    Nat Genet; 1997 Apr; 15(4):406-10. PubMed ID: 9090389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectral karyotyping and interphase FISH reveal abnormalities not detected by conventional G-banding. Implications for treatment stratification of childhood acute lymphoblastic leukaemia: detailed analysis of 70 cases.
    Nordgren A; Heyman M; Sahlén S; Schoumans J; Söderhäll S; Nordenskjöld M; Blennow E
    Eur J Haematol; 2002 Jan; 68(1):31-41. PubMed ID: 11952819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectral karyotyping analysis of head and neck squamous cell carcinoma.
    Singh B; Gogineni S; Goberdhan A; Sacks P; Shaha A; Shah J; Rao P
    Laryngoscope; 2001 Sep; 111(9):1545-50. PubMed ID: 11568603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of complex chromosomal aberrations in patients with myelodysplastic syndromes using multiplex fluorescence in situ hybridization combined with whole chromosome painting].
    Chen LJ; Li JY; Xiao B; Zhu Y; Liu Q; Pan JL; Qiu HR; Fan L; Zhang SJ; Lu RN; Xu W; Xue YQ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Dec; 24(6):635-9. PubMed ID: 18067073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectral karyotyping and fluorescence in situ hybridization detect novel chromosomal aberrations, a recurring involvement of chromosome 21 and amplification of the MYC oncogene in acute myeloid leukaemia M2.
    Hilgenfeld E; Padilla-Nash H; McNeil N; Knutsen T; Montagna C; Tchinda J; Horst J; Ludwig WD; Serve H; Büchner T; Berdel WE; Schröck E; Ried T
    Br J Haematol; 2001 May; 113(2):305-17. PubMed ID: 11380393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in the detection of chromosomal aberrations using spectral karyotyping.
    Bayani J; Squire JA
    Clin Genet; 2001 Feb; 59(2):65-73. PubMed ID: 11260203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular cytogenetic characterization of the KG-1 and KG-1a acute myeloid leukemia cell lines by use of spectral karyotyping and fluorescence in situ hybridization.
    Mrózek K; Tanner SM; Heinonen K; Bloomfield CD
    Genes Chromosomes Cancer; 2003 Nov; 38(3):249-52. PubMed ID: 14506699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined spectral karyotyping and DAPI banding analysis of chromosome abnormalities in myelodysplastic syndrome.
    Kakazu N; Taniwaki M; Horiike S; Nishida K; Tatekawa T; Nagai M; Takahashi T; Akaogi T; Inazawa J; Ohki M; Abe T
    Genes Chromosomes Cancer; 1999 Dec; 26(4):336-45. PubMed ID: 10534769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectral karyotyping identifies new rearrangements, translocations, and clinical associations in diffuse large B-cell lymphoma.
    Nanjangud G; Rao PH; Hegde A; Teruya-Feldstein J; Donnelly G; Qin J; Jhanwar SC; Zelenetz AD; Chaganti RS
    Blood; 2002 Apr; 99(7):2554-61. PubMed ID: 11895793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of marker or complex chromosomal rearrangements present in pre- and post-natal karyotypes utilizing a combination of G-banding, spectral karyotyping and fluorescence in situ hybridization.
    Heng HH; Ye CJ; Yang F; Ebrahim S; Liu G; Bremer SW; Thomas CM; Ye J; Chen TJ; Tuck-Muller C; Yu JW; Krawetz SA; Johnson A
    Clin Genet; 2003 May; 63(5):358-67. PubMed ID: 12752567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of uncommon chromosomal aberrations in the neuroglioma cell line H4 by spectral karyotyping.
    Krex D; Mohr B; Hauses M; Ehninger G; Schackert HK; Schackert G
    J Neurooncol; 2001 Apr; 52(2):119-28. PubMed ID: 11508811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicolor banding technique, spectral color banding (SCAN): new development and applications.
    Kakazu N; Abe T
    Cytogenet Genome Res; 2006; 114(3-4):250-6. PubMed ID: 16954662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of recurrent chromosomal breakpoints in multiple myeloma with complex karyotypes by combined G-banding, spectral karyotyping, and fluorescence in situ hybridization analyses.
    Sáez B; Martín-Subero JI; Largo C; Martín MC; Odero MD; Prosper F; Siebert R; Calasanz MJ; Cigudosa JC
    Cancer Genet Cytogenet; 2006 Sep; 169(2):143-9. PubMed ID: 16938572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of complex chromosomal abnormalities in B-cell lymphoma by a combined spectral karyotyping (SKY) analysis and fluorescence in situ hybridization (FISH) using a 14q telomere probe.
    Kakazu N; Kito K; Hitomi T; Oita J; Nishida K; Masuda K; Miki T; Abe T
    Am J Hematol; 2000 Dec; 65(4):291-7. PubMed ID: 11074557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unraveling the chromosome 17 patterns of FISH in interphase nuclei: an in-depth analysis of the HER2 amplicon and chromosome 17 centromere by karyotyping, FISH and M-FISH in breast cancer cells.
    Rondón-Lagos M; Verdun Di Cantogno L; Rangel N; Mele T; Ramírez-Clavijo SR; Scagliotti G; Marchiò C; Sapino A
    BMC Cancer; 2014 Dec; 14():922. PubMed ID: 25481507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytogenetic characterization of NCI-H69 and NCI-H69AR small cell lung cancer cell lines by spectral karyotyping.
    Salido M; Arriola E; Carracedo A; Cañadas I; Rovira A; Espinet B; Rojo F; Arumi M; Serrano S; Albanell J; Sole F
    Cancer Genet Cytogenet; 2009 Jun; 191(2):97-101. PubMed ID: 19446745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.